Ozempic maker Novo Nordisk downgraded to sell following 70% stock-price dive from peak
Ozempic maker Novo Nordisk downgraded to sell following 70% stock-price dive from peak MarketWatch
Covered in this story
Summary aggregated from MarketWatch's public RSS feed. The full reporting belongs to MarketWatch — please read it on their site.